ADVENTHEALTH ZEPHYRHILLS — History
CCN 100046 | 3-year financial timeline | COVID resilience: 71/100
🛡️ Public data only — no PHI permitted on this instance.
$207M
Latest Revenue (FY2022)
+10.9%
Revenue CAGR (3yr)
-0.8%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $168M | $199M | $207M | +4.3% | +10.9% |
| Operating Expenses | $176M | $196M | $209M | +6.3% | +9.0% |
| Operating Margin | -4.4% | 1.1% | -0.8% | -173.4% | +0.0% |
| Net Income | $-7M | $2M | $-2M | -176.5% | +0.0% |
| Licensed Beds | 149 | 149 | 149 | +0.0% | +0.0% |
| Total Patient Days | 37,932 | 42,350 | 42,102 | -0.6% | +5.4% |
| Medicare Day % | 26% | 23% | 21% | -4.9% | -9.2% |
| Medicaid Day % | 3% | 3% | 3% | -22.9% | -12.0% |
COVID Impact & Recovery
Resilience Score: 71/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +22.9% ($168M → $207M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+10.9%
This Hospital
+7.6%
State Avg
Latest Margin
-0.8%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $226M | 0.9% |
| FY2024 (proj) | $246M | 2.7% |
| FY2025 (proj) | $265M | 4.5% |